Biofilm formation of Candida spp. isolates from patients at a cardiothoracic intensive care unit

International Journal of Artificial Organs

Volumn 34, Issue 9, 2011, Pages 818-823

  Tobudic, Selma ^a   Kratzer, Christina ^a   Lassnigg, Andrea ^a   Willinger, Birgit ^a   Graninger, Wolfgang ^a   Presterl, Elisabeth ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biofilm; Candida spp.; Invasive isolates; Non invasive isolates

Indexed keywords

BIOFILMS; INTENSIVE CARE UNITS; YEAST;

BIO-FILM THICKNESS; BIOFILM FORMATION; CANDIDA SPP; CANDIDA SPP.; COLONISATION; CRYSTAL VIOLET; INVASIVE ISOLATE; METABOLIC ACTIVITY; NON-INVASIVE ISOLATE; VIRULENCE FACTORS;

CANDIDA;

CRYSTAL VIOLET; NANDROLONE PHENPROPIONATE; VIRULENCE FACTOR;

ADULT; ARTICLE; BIOFILM; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CELL ACTIVITY; CELL METABOLISM; COMPARATIVE STUDY; FEMALE; FUNGAL CELL; HEART SURGERY; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORTALITY; OUTCOME ASSESSMENT; STAINING; SURGICAL PATIENT;

EID: 81355163361     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000028     Document Type: Article

References (15)

1. Presterl E, Parschalk B, Bauer E, Lassnigg A, Hajdu S, Graninger W. Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients. Int J Infect Dis. 2009;13(6):707-712.
2. Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest. 2003;124(6):2244-2255.
3. Kett DH, Azoulay E, Echeverria PM, Vincent JL. Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in a intensive care unit study. Crit Care Med. 2011;39(4):665-670.
4. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005;28(11):1062-1068.
5. Nguyen MH, Peacock JE Jr, Tanner DC, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med. 1995;155(22):2429-2435.
6. Tobudic S, Lassnigg A, Kratzer C, Graninger W, Presterl E. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. Mycoses. 2010;53(3):208-214.
7. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003;11(1):30-36.
8. Tumbarello M, Posteraro B, Trecarichi EM, et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol. 2007;45(6):1843-1850.
9. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001;45(9):2475-2479.
10. Shin JH, Kee SJ, Shin MG, et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol. 2002;40(4):1244-1248.
11. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun. 1994;62(3):915-921.
12. Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22(6):996-1006.
13. Chandra J, Mukherjee PK, Leidich SD, et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res. 2001;80(3):903-908.
14. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183(18):5385-5394.
15. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun. 2002;70(2):878-888.